Abeona Therapeutics competitors

Abeona Therapeutics's competitors include Solid BioSciences, miRagen Therapeutics, GenVec and Exonics Therapeutics
Add company...
Abeona Therapeutics
Abeona Therapeutics is focusing on developing innovative therapies, including gene therapies, for rare diseases, including Sanfilippo Syndrome.
Solid BioSciences
Solid Biosciences is a life science company focused on solving Duchenne muscular dystrophy.
miRagen Therapeutics
miRagen Therapeutics is focused on developing therapeutics for the treatment of cardiovascular and muscle diseases.
GenVec
GenVec is a clinical-stage biopharmaceutical company focusing on developing a pipeline of therapeutics and vaccines through its proprietary AdenoVerse gene delivery platform.
Exonics Therapeutics
Exonics Therapeutics develops gene editing technologies to permanently correct the majority of duchenne muscular dystrophy mutations.
Founding Date
Founding Date
2013
Founding Date
2013
Founding Date
2007
Founding Date
1992
Founding Date
2017
Type
Type
Public
Type
Public
Type
Public
Type
Subsidiary
Type
Private
Tags
Locations
Locations
Dallas, US HQ
Locations
Cambridge, US HQ
Greater London, GB
Greater London, GB
New York, US
Locations
Boulder, US HQ
Locations
Gaithersburg, US HQ
Locations
Cambridge, US HQ
Dallas, US
Employees
Employees
19217% increase
Employees
627% increase
Employees
51
Employees
1570% decrease
Employees
N/A
Valuation ($)
Valuation ($)
752.2 m
Valuation ($)
875.6 m
Valuation ($)
219.5 m
Valuation ($)
N/A
Valuation ($)
N/A
Facebook likes
Facebook likes
2.3 k
Facebook likes
N/A
Facebook likes
N/A
Facebook likes
296
Facebook likes
N/A
Twitter followers
Twitter followers
709
Twitter followers
225
Twitter followers
395
Twitter followers
268
Twitter followers
96

Financial

Revenue (est.)
Revenue (est.)
$837k (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$511k (FY, 2016)
Revenue (est.)
N/A
Net income
Net income
($27.3m) (FY, 2017)
Net income
N/A
Net income
N/A
Net income
($5.8m) (FY, 2016)
Net income
N/A

Funding

Total funding raised
Total funding raised
$ 128.7m
Total funding raised
$ 92.5m
Total funding raised
N/A
Total funding raised
$ 2m
Total funding raised
$ 45m
For sources of this data, please see the company profileDownload Excel

View company profiles

Solid BioSciences
HQ
Cambridge, US
Employees
62↑ 7% increase

Solid Biosciences is a life science company focused on solving Duchenne muscular dystrophy.

View company
miRagen Therapeutics
HQ
Boulder, US
Employees
51

miRagen Therapeutics is focused on developing therapeutics for the treatment of cardiovascular and muscle diseases.

View company
GenVec
HQ
Gaithersburg, US

GenVec is a clinical-stage biopharmaceutical company focusing on developing a pipeline of therapeutics and vaccines through its proprietary AdenoVerse gene delivery platform.

View company
Exonics Therapeutics
HQ
Cambridge, US

Exonics Therapeutics develops gene editing technologies to permanently correct the majority of duchenne muscular dystrophy mutations.

View company